Effect of additional intravenous immunoglobulin for infliximab-refractory Kawasaki disease: a cohort study

  1. Satoki Hatano
  2. Hiro Nakao
  3. Hiroshi Masuda
  4. Hiroshi Ono
  5. Mitsuru Kubota
  6. Akira Ishiguro
Read the full article See related articles

Listed in

This article is not in any list yet, why not save it to one of your lists.
Log in to save this article

Abstract

No abstract available

Article activity feed

  1. Version published to 10.1186/s12969-025-01108-0
  2. Version published to 10.21203/rs.3.rs-5421198/v1 on Research Square